The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2020)Colorectal cancer statistics, 2020 CA Cancer J Clin 70 145-164

[3] Siegel RL(2012)Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933

[4] Laversanne M(2006)Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620-4625

[5] Soerjomataram I(2021)Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 19 329-359

[6] Jemal A(2020)Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 31 1291-1305

[7] Siegel RL(2010)Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 835-844

[8] Miller KD(2020)Outcome measures in multimodal rectal cancer trials Lancet Oncol 21 e252-e264

[9] Goding Sauer A(2012)Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy World J Surg 36 675-683

[10] Fedewa SA(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2020)Colorectal cancer statistics, 2020 CA Cancer J Clin 70 145-164

[3] Siegel RL(2012)Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933

[4] Laversanne M(2006)Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620-4625

[5] Soerjomataram I(2021)Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 19 329-359

[6] Jemal A(2020)Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 31 1291-1305

[7] Siegel RL(2010)Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 835-844

[8] Miller KD(2020)Outcome measures in multimodal rectal cancer trials Lancet Oncol 21 e252-e264

[9] Goding Sauer A(2012)Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy World J Surg 36 675-683

[10] Fedewa SA(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776